{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:04:27Z","timestamp":1791993867938,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jaip.2025.08.027","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T22:12:28Z","timestamp":1757110348000},"page":"3264-3273.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Observational Analysis of Biological Remission as a Treatment Target for Severe Asthma: UK Severe Asthma Registry"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2063-7992","authenticated-orcid":false,"given":"P. Jane","family":"McDowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Redmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Busby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pujan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel H.","family":"Mansur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Burhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitasha","family":"Rupani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam G.","family":"Heaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.08.027_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaci.2019.12.006","article-title":"An expert consensus framework for asthma remission as a treatment goal","volume":"145","author":"Menzies-Gow","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.08.027_bib2","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/ecco-jcc\/jjad086","article-title":"Defining biological remission in Crohn\u2019s disease: interest, challenges and future directions","volume":"17","author":"Pierre","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jaip.2025.08.027_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41584-020-00543-5","article-title":"Why remission is not enough: underlying disease mechanisms in rheumatoid arthritis that prevent cure","volume":"17","author":"Schett","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaip.2025.08.027_bib4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/ard.2006.057497","article-title":"Radiological damage in patients with rheumatoid arthritis on sustained remission","volume":"66","author":"Cohen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2025.08.027_bib5","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S2213-2600(15)00367-7","article-title":"Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study","volume":"3","author":"Price","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.08.027_bib6","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S2213-2600(21)00124-7","article-title":"Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate to severe asthma receiving placebo in the Liberty Asthma Quest study a post hoc analysis","volume":"9","author":"Busse","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.08.027_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13601-019-0282-7","article-title":"Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations","volume":"9","author":"Price","year":"2019","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2025.08.027_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/thoraxjnl-2021-217325","article-title":"Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide","volume":"7","author":"Couillard","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.08.027_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.156091","article-title":"IL-4 and IL13, not eosinophils, drive type 2 airways inflammation, remodelling and lung function decline","volume":"162","author":"Scott","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.jaip.2025.08.027_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/1744666X.2020.1860755","article-title":"The emerging role of type 2 inflammation in asthma","volume":"17","author":"Matucci","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2025.08.027_bib11","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1084\/jem.167.5.1737","article-title":"Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophilic chemotactic factor","volume":"167","author":"Yamaguchi","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaip.2025.08.027_bib12","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3389\/fphys.2019.01514","article-title":"Interleukin-5 in the pathophysiology of severe asthma","volume":"10","author":"Pelaia","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.jaip.2025.08.027_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/thoraxjnl-2014-205634","article-title":"External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma","volume":"70","author":"Wagener","year":"2025","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.08.027_bib15","first-page":"220","volume":"76","author":"Jackson","year":"2021"},{"key":"10.1016\/j.jaip.2025.08.027_bib16","first-page":"787","volume":"65","author":"Heaney","year":"2010","journal-title":"Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry"},{"key":"10.1016\/j.jaip.2025.08.027_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.08.027_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2025.08.027_bib19","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1164\/ajrccm.162.4.9912140","article-title":"Duration of asthma and physiologic outcomes in elderly nonsmokers","volume":"162","author":"Cassino","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2025.08.027_bib20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1164\/ajrccm.162.2.9907151","article-title":"The effect of age and duration of disease on airway structure in fatal asthma","volume":"162","author":"Bai","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2025.08.027_bib21","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02173-2017","article-title":"Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis","volume":"51","author":"Takahashi","year":"2018","journal-title":"Eur Resp J"},{"key":"10.1016\/j.jaip.2025.08.027_bib22","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1183\/13993003.00850-2016","article-title":"The effect of smoking on lung function: a clinical study of adult-onset asthma","volume":"48","author":"Tommola","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.08.027_bib23","doi-asserted-by":"crossref","first-page":"00320","DOI":"10.1183\/23120541.00320-2020","article-title":"Blood eosinophil level and lung function trajectories: cross-sectional and longitudinal studies in European cohorts","volume":"6","author":"Mogensen","year":"2020","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2025.08.027_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S2213-2600(22)00185-0","article-title":"Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study","volume":"11","author":"Kole","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.08.027_bib25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(23)02284-5","article-title":"Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open label, phase 4 study","volume":"403","author":"Jackson","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.08.027_bib26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.alit.2015.12.006","article-title":"Persistently high exhaled nitric oxide and loss of lung function in controlled asthma","volume":"65","author":"Matsunaga","year":"2016","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2025.08.027_bib27","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1164\/rccm.202311-2192OC","article-title":"Exploring definitions and predictors of severe asthma clinical remission after biologic treatment in adults","volume":"210","author":"Perez-de-Llano","year":"2024","journal-title":"Am J Respir Crit Care"},{"key":"10.1016\/j.jaip.2025.08.027_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.chest.2023.10.046","article-title":"Clinical response and remission in patients with severe asthma treated with biologic therapies","volume":"165","author":"Hansen","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.08.027_bib29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/all.15867","article-title":"Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients","volume":"79","author":"Thomas","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.08.027_bib30","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00819-2023","article-title":"Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry","volume":"62","author":"McDowell","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.08.027_bib31","first-page":"23","article-title":"Clinical remission attainment, definitions and correlates among patients with severe asthma treated with biologics: a systematic review and meta-analysis","volume":"1","author":"Shackleford","year":"2024","journal-title":"Lancet Respir Med"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825008281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825008281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:06:16Z","timestamp":1778893576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825008281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2213219825008281"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.08.027","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Observational Analysis of Biological Remission as a Treatment Target for Severe Asthma: UK Severe Asthma Registry","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}